RT @SABOURETCardio
Modulation and personalization of therapy after acute coronary syndromes... https://youtu.be/1PqXutMtZZI via @YouTube #DAPT De Escalation #LLT #UpfrontStrategy #SAPT #EHJ

RT @ehj_ed
Unmet needs in valvular heart disease: check the latest State of the Art Review in #EHJ!

https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehad121/7078714

#VHD #outcome #intervention #epidemiology #cardiotwitter @escardio @ESC_Journals

RT @ehj_ed
A genome-wide study in aortic stenosis! Look at the 15 genetic loci involved in dyslipidemia, inflammation, calcification, and adiposity!

#aortic #stenosis #gene
https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehad142/7112365
#ehj #cardiotwitter @ESC_Journals @escardio

Wie verbreitet ist das FFR-basierte Vorgehen bei den Nicht-Infarkt-Gefäßen in Deutschland mittlerweile, liebes #KardioTwitter?

RT @ESC_Journals@twitter.com

Fractional flow reserve versus angiography-guided strategy in acute myocardial infarction with multivessel disease: a randomized trial https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehac763/6948120

@escardio@twitter.com #EHJ #ESCYoung #cardiotwitter @ehj_ed@twitter.com @rladeiraslopes@twitter.com

🐦🔗: https://twitter.com/ESC_Journals/status/1612705867786338305

RT @mvaduganathan
A Welcome ‘Failure’ of Gliflozins: #BloodPressure Reduction in #HeartFailure in @escardio #EHJ

@Kieranfdocherty & @PSJhund highlight the relative hemodynamical neutrality of #SGLT2i in HF, facilitating their ease of use.

Average BP ↓ of just <2-3mmHg!

https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehac712/6895825